UltraCharge clinches key partnership with Sinochem
UltraCharge Limited (ASX:UTR) has entered into a Memorandum of Understanding (MOU) with China’s leading fluorine chemical manufacturer, Sinochem Lantian Co. Ltd. Sinochem Lantian is a subsidiary of Sinochem Group, which is a Chinese state-owned Fortune Global 500 company.
Having recently acquired a high performing, low cost electrolyte solution from Coorstek Speciality Chemicals, UTR’s electrolyte IP will facilitate the production of a superior electrolyte salt (LiFSI salt), which can increase battery lifespan and performance.
Because Sinochem Lantian is one of just several companies that produce LiFSI salt, the MOU is a crucial step forward for the company — which aims to produce a commercial lithium-ion battery solution.
Furthermore, the MOU provides an invaluable opportunity for UTR to capitalise on the burgeoning Chinese electric vehicle market. Due to its government’s policy on clean driving and greenhouse emissions, China has become the world’s leading electric vehicle consumer.
UTR believes its lithium-ion battery solutions are well suited to satisfy the increasing demand and market requirements of Chinese electric vehicle manufacturers.
“We are very pleased to be in partnership with Sinochem Lantian to develop our electrolyte IP,” UTR CEO, Kobi Ben-Shabat said.
“We are now in a position to offer battery manufacturers a full or tailored solution to enhance performance of lithium ion batteries. For the end user or consumer, this means a longer lifespan, higher voltage, low cost battery solution which is safe,” he said.
It should be noted here that UTR remains a speculative company and investors should seek professional financial advice if considering this stock for their portfolio.
An Israel-based company, UTR is focused on developing electric battery technologies. Its growing IP of battery tech includes:
- Anode for lithium-ion batteries: UTR has the exclusive rights to patented anode technology from Nanyang Technology in Singapore. This tech could provide a safer and faster charging battery by replacing the graphite in battery anodes with nanotube fibres made from titanium oxide.
- Cathode for lithium-ion batteries: The company has agreed to acquire the IP from ETV Energy in Israel. This IP could enable UTR to produce cathodes at half the cost of current commercial offerings.
- Electrolyte in lithium-ion batteries: UTR has now acquired a low cost, high performing electrolyte solution from US based company, Coorstek Speciality Chemicals. This IP is based around producing a superior electrolyte salt (LiFSI), which could significantly increase battery lifespan and performance.
- Ion flow battery: UTR has an exclusive licence agreement with Israeli company Epsilor. The agreement will provide access to Epsilor’s new ion flow battery tech, which is the only commercially viable energy storage of its type to date. It also boasts lower installation and operation costs than current market alternatives.
When the experts at Next Investors have a stock pick, it may pay to listen.
The Next Investors have been investing in ASX small cap stocks for years, with their best small cap picks yielding returns of 1,200%, 1,120%, 900% and 678%.
They have just revealed their hand-picked, FY2021 stock portfolio of high conviction long-term investments.
Click the link below to see what they are currently investing in.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.